Prevalence of exercise-induced pulmonary hemorrhage in competing endurance horses

Icíar Tarancón 1Servei de Medicina Interna Equina, Unitat Equina-Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Search for other papers by Icíar Tarancón in
Current site
Google Scholar
PubMed
Close
 DVM
,
Lara Armengou 1Servei de Medicina Interna Equina, Unitat Equina-Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Search for other papers by Lara Armengou in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Antonio Melendez-Lazo 2Servei d'Hematologia, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Search for other papers by Antonio Melendez-Lazo in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Josep Pastor 2Servei d'Hematologia, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Search for other papers by Josep Pastor in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
José Ríos 3Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, and Laboratori de Biostadística i Epidemiologia, Facultad de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
4Unitat de Suport Estadístic i Metodològic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic de Barcelona, Carrer del Rosselló, 149, 08036 Barcelona, Spain.

Search for other papers by José Ríos in
Current site
Google Scholar
PubMed
Close
 MSc
, and
Eduard Jose-Cunilleras 1Servei de Medicina Interna Equina, Unitat Equina-Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.

Search for other papers by Eduard Jose-Cunilleras in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

OBJECTIVE

To assess the prevalence of exercise-induced pulmonary hemorrhage (EIPH) among elite endurance horses after competition in a long-distance race.

ANIMALS

20 endurance horses and 12 nonexercised or minimally exercised age-, breed-, and trainer-matched horses from the same environment (control horses).

PROCEDURES

Bronchoalveolar lavage fluid samples collected from endurance horses at 3 to 8 days (sample A) and 36 to 38 days (sample B) after the race (100 km in 1 day [n = 3], 70 km/d for 2 days [12], or 100 km/d for 2 days [5]) were cytologically examined for the presence of hemosiderophages. Samples from control horses were collected at the same time as sample B was obtained from respective matched endurance horses and similarly examined. Horses with bronchoalveolar lavage fluid samples in which > 1% of identified cells were hemosiderophages were considered to have evidence of EIPH.

RESULTS

Of 20 endurance horses, 9 (45%; 95% confidence interval, 25% to 66%) and 10 (50%; 95% confidence interval, 29% to 71%) had cytologic evidence of EIPH in samples A and B, respectively. Evidence of EIPH was present in 6 of 20 (30%) horses at both sample collection times, 3 (15%) at the first sample time only, and 4 (20%) at the second sample time only. In contrast, 1 of 12 control horses had cytologic evidence of EIPH.

CONCLUSIONS AND CLINICAL RELEVANCE

The prevalence of EIPH in these elite endurance horses (45% to 50%) was higher than previously reported estimates for poor-performing endurance horses; however, differences in criteria for identification of EIPH should be considered when comparing findings between studies.

Abstract

OBJECTIVE

To assess the prevalence of exercise-induced pulmonary hemorrhage (EIPH) among elite endurance horses after competition in a long-distance race.

ANIMALS

20 endurance horses and 12 nonexercised or minimally exercised age-, breed-, and trainer-matched horses from the same environment (control horses).

PROCEDURES

Bronchoalveolar lavage fluid samples collected from endurance horses at 3 to 8 days (sample A) and 36 to 38 days (sample B) after the race (100 km in 1 day [n = 3], 70 km/d for 2 days [12], or 100 km/d for 2 days [5]) were cytologically examined for the presence of hemosiderophages. Samples from control horses were collected at the same time as sample B was obtained from respective matched endurance horses and similarly examined. Horses with bronchoalveolar lavage fluid samples in which > 1% of identified cells were hemosiderophages were considered to have evidence of EIPH.

RESULTS

Of 20 endurance horses, 9 (45%; 95% confidence interval, 25% to 66%) and 10 (50%; 95% confidence interval, 29% to 71%) had cytologic evidence of EIPH in samples A and B, respectively. Evidence of EIPH was present in 6 of 20 (30%) horses at both sample collection times, 3 (15%) at the first sample time only, and 4 (20%) at the second sample time only. In contrast, 1 of 12 control horses had cytologic evidence of EIPH.

CONCLUSIONS AND CLINICAL RELEVANCE

The prevalence of EIPH in these elite endurance horses (45% to 50%) was higher than previously reported estimates for poor-performing endurance horses; however, differences in criteria for identification of EIPH should be considered when comparing findings between studies.

Supplementary Materials

    • Supplementary Table S1 (PDF 76 kb)
All Time Past Year Past 30 Days
Abstract Views 196 0 0
Full Text Views 1705 1309 53
PDF Downloads 776 313 34
Advertisement